Mirati Therapeutics, Inc. (MRTX) Social Stream



Mirati Therapeutics, Inc. (MRTX): $58.70

0.10 (-0.17%)

POWR Rating

Component Grades

Momentum

F

Stability

F

Sentiment

Quality

D

Add MRTX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#304 of 359

in industry

MIRATI THERAPEUTICS INC (MRTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering MIRATI THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 10 $235 $171 $198.857 $58.9 237.62%
2021-11-16 10 $235 $171 $197 $58.9 234.47%
2021-11-19 11 $235 $171 $195.75 $58.9 232.34%
2022-01-31 10 $235 $171 $195.75 $58.9 232.34%
2022-02-01 9 $235 $141 $188.875 $58.9 220.67%
2022-02-16 10 $219 $141 $173.125 $58.9 193.93%
2022-02-17 10 $219 $121 $159.75 $58.9 171.22%
2022-03-01 10 $219 $118 $154.5 $58.9 162.31%
2022-04-28 10 $203 $117 $147.125 $58.9 149.79%
2022-05-04 10 $203 $99 $138.75 $58.9 135.57%
2022-05-06 10 $208 $99 $138.444 $58.9 135.05%
2022-05-12 10 $208 $99 $140.444 $58.9 138.44%
2022-05-20 12 $208 $99 $137.9 $58.9 134.13%
2022-05-26 12 $216 $82 $143.454 $58.9 143.56%
2022-06-01 11 $216 $82 $136.09 $58.9 131.05%
2022-06-07 11 $208 $72 $128.083 $58.9 117.46%
2022-07-27 12 $188 $72 $121.916 $58.9 106.99%
2022-08-04 12 $188 $79 $120.916 $58.9 105.29%
2022-08-08 13 $188 $85 $124.636 $58.9 111.61%
2022-08-18 13 $188 $85 $123.333 $58.9 109.39%
2022-09-17 14 $188 $85 $122.538 $58.9 108.04%
2022-10-12 14 $188 $85 $121.384 $58.9 106.08%
2022-10-14 14 $188 $85 $121.307 $58.9 105.95%
2022-11-09 15 $188 $72 $117.785 $58.9 99.97%
2022-11-16 15 $188 $72 $116.357 $58.9 97.55%
2022-11-30 14 $188 $72 $111.692 $58.9 89.63%
2022-12-09 15 $188 $52 $88.357 $58.9 50.01%
2022-12-12 15 $188 $52 $86 $58.9 46.01%
2022-12-13 16 $188 $52 $85.285 $58.9 44.8%
2022-12-14 16 $188 $52 $83.714 $58.9 42.13%
2023-01-23 16 $188 $53 $84.4 $58.9 43.29%
2023-01-26 16 $188 $53 $81.4 $58.9 38.2%
2023-02-08 16 $188 $50 $80.733 $58.9 37.07%
2023-03-01 15 $188 $50 $80.733 $58.9 37.07%
2023-04-25 16 $188 $50 $79.6 $58.9 35.14%
2023-05-10 16 $188 $50 $76.333 $58.9 29.6%
2023-05-11 15 $188 $50 $73.357 $58.9 24.54%
2023-05-29 14 $188 $40 $70.153 $58.9 19.11%
2023-06-06 14 $82 $40 $60.416 $58.9 2.57%
2023-07-13 14 $82 $40 $60.333 $58.9 2.43%
2023-07-14 14 $82 $40 $59.666 $58.9 1.3%
2023-07-24 15 $82 $40 $59.153 $58.9 0.43%
2023-07-26 15 $82 $40 $58.846 $58.9 -0.09%
2023-08-09 16 $82 $40 $58.846 $58.9 -0.09%
2023-09-21 17 $83 $31 $54.5 $58.9 -7.47%
2023-09-28 17 $83 $31 $54.285 $58.9 -7.84%
2023-10-05 17 $83 $31 $55.714 $58.9 -5.41%
2023-10-09 17 $83 $37 $61.133 $58.9 3.79%
2023-10-10 17 $83 $37 $62 $58.9 5.26%
2023-10-25 16 $83 $37 $62 $58.9 5.26%
2023-11-06 16 $83 $37 $62 $58.9 5.26%
2023-11-07 16 $82 $37 $59.066 $58.9 0.28%
2023-12-19 16 $91 $45 $63.4 $58.9 7.64%

The Trend in the Analyst Price Target


MRTX's average price target has moved down $81.6 over the prior 19 months.

MRTX reports an average of 53.77% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-26 16 188 53 81.400 51.06 59.42%
2023-04-17 16 188 50 79.600 42.24 88.45%
2023-05-29 15 188 40 70.153 38.46 82.41%
2023-07-14 14 82 40 59.583 35.43 68.17%
2023-08-09 16 82 40 58.846 37.00 59.04%

MRTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.63 3 0 13 0 0 16

The Trend in the Broker Recommendations


MRTX's average broker recommendation rating worsened by 1 over the prior 46 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how MIRATI THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -6079.95% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MIRATI THERAPEUTICS INC's average analyst price target is higher than 6347.87% of them.
  • In the context of Pharmaceutical Products stocks, MIRATI THERAPEUTICS INC's number of analysts covering the stock is greater than 6264.14% of them.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, MIRATI THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 5358.38% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MIRATI THERAPEUTICS INC are LEGN, CVAC, and QGEN.

Is MRTX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!